1
|
Zeng JH, Qiu P, Xiong L, Liu SW, Ding LH, Xiong SL, Li JT, Xiao ZB, Zhang T. Bone repair scaffold coated with bone morphogenetic protein-2 for bone regeneration in murine calvarial defect model: Systematic review and quality evaluation. Int J Artif Organs 2019; 42:325-337. [PMID: 30905250 DOI: 10.1177/0391398819834944] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/08/2023]
Abstract
To systematically assess the effects of hydroxyapatite bone repair scaffold coated with bone morphogenetic protein-2 on murine calvarial defect models and to determine the quality of studies according to the Animal Research Reporting in In Vivo Experiments guidelines. Internet search was performed in duplicate using PubMed, MEDLINE, Ovid and Embase databases (without restrictions on publication date). The Animal Research Reporting in In Vivo Experiments guidelines were used to evaluate the quality of selected studies. Following screening, 12 studies were eligible for the review. Studies with average quality coefficients predominated (66.67%), followed by poor (25%) and excellent (8.33%) quality coefficients. Minimum quality scores were assigned to the Animal Research Reporting in In Vivo Experiments guideline items: housing and husbandry (9), allocation (11), outcomes (12), interpretation (18) and generalizability (19). Sprague–Dawley rats were the most frequently used (50%) species, and most studies had a sample size of more than 30 (58.33%). A defect dimension of 5 mm was the most common (33.33%). The biological hydroxyapatite composite scaffold was common (50%), and the bioactive factors were bone morphogenetic protein-2 (50%) and recombinant human bone morphogenetic protein-2 (50%). Histomorphometric results showed that bone morphogenetic protein-2 enhanced the capacity to regenerate bone considerably. In addition, scaffolds with bone morphogenetic protein-2 resulted in a significant increase in the blood vessel in the new bone. The findings suggested that data on animal experiments of hydroxyapatite scaffold coated with bone morphogenetic protein-2 in murine calvarial defect models lack homogeneity. Animal experiment should follow the Animal Research Reporting in In Vivo Experiments guidelines to promote the high quality, integrity and reproducibility. This systematic review suggested that bone morphogenetic protein-2 enhanced the capacity to regenerate bone and the angiogenesis in the new bone.
Collapse
Affiliation(s)
- Jian-Hua Zeng
- Department of Orthopaedics, Jiangxi Provincial People’s Hospital Affiliated to Nanchang University, Nanchang, P.R. China
| | - Peng Qiu
- Department of Orthopaedics, Jiangxi Provincial People’s Hospital Affiliated to Nanchang University, Nanchang, P.R. China
| | - Long Xiong
- Department of Orthopaedics, Jiangxi Provincial People’s Hospital Affiliated to Nanchang University, Nanchang, P.R. China
| | - Shi-Wei Liu
- Department of Orthopaedics, Jiangxi Provincial People’s Hospital Affiliated to Nanchang University, Nanchang, P.R. China
| | - Ling-Hua Ding
- Department of Orthopaedics, Jiangxi Provincial People’s Hospital Affiliated to Nanchang University, Nanchang, P.R. China
| | | | - Jing-Tang Li
- Department of Orthopaedics, Jiangxi Provincial People’s Hospital Affiliated to Nanchang University, Nanchang, P.R. China
| | - Ze-Bu Xiao
- Department of Rehabilitation Medicine, Jiangxi Provincial People’s Hospital Affiliated to Nanchang University, Nanchang, P.R. China
| | - Tao Zhang
- Department of Orthopaedics, Jiangxi Provincial People’s Hospital Affiliated to Nanchang University, Nanchang, P.R. China
| |
Collapse
|
2
|
Ordinary and Activated Bone Grafts: Applied Classification and the Main Features. BIOMED RESEARCH INTERNATIONAL 2015; 2015:365050. [PMID: 26649300 PMCID: PMC4662978 DOI: 10.1155/2015/365050] [Citation(s) in RCA: 26] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 05/23/2015] [Accepted: 10/15/2015] [Indexed: 12/19/2022]
Abstract
Bone grafts are medical devices that are in high demand in clinical practice for substitution of bone defects and recovery of atrophic bone regions. Based on the analysis of the modern groups of bone grafts, the particularities of their composition, the mechanisms of their biological effects, and their therapeutic indications, applicable classification was proposed that separates the bone substitutes into “ordinary” and “activated.” The main differential criterion is the presence of biologically active components in the material that are standardized by qualitative and quantitative parameters: growth factors, cells, or gene constructions encoding growth factors. The pronounced osteoinductive and (or) osteogenic properties of activated osteoplastic materials allow drawing upon their efficacy in the substitution of large bone defects.
Collapse
|
3
|
Shapiro G, Kallai I, Sheyn D, Tawackoli W, Koh YD, Bae H, Trietel T, Goldbart R, Kost J, Gazit Z, Gazit D, Pelled G. Ultrasound-mediated transgene expression in endogenous stem cells recruited to bone injury sites. POLYM ADVAN TECHNOL 2014. [DOI: 10.1002/pat.3297] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/19/2023]
Affiliation(s)
- Galina Shapiro
- Skeletal Biotech Laboratory; Hebrew University-Hadassah Faculty of Dental Medicine; Jerusalem Israel
| | - Ilan Kallai
- Skeletal Biotech Laboratory; Hebrew University-Hadassah Faculty of Dental Medicine; Jerusalem Israel
| | - Dmitriy Sheyn
- Department of Surgery; Cedars-Sinai Medical Center; Los Angeles CA 90048 United States
| | - Wafa Tawackoli
- Department of Surgery; Cedars-Sinai Medical Center; Los Angeles CA 90048 United States
- Biomedical Imaging Research Institute; Cedars-Sinai Medical Center; Los Angeles CA 90048 United States
| | - Young Do Koh
- Orthopedic Surgery; Ewha Womans University; Seoul Democratic People's Republic of Korea
| | - Hyun Bae
- Department of Surgery; Cedars-Sinai Medical Center; Los Angeles CA 90048 United States
| | - Tamar Trietel
- Department of Chemical Engineering; Ben-Gurion University of the Negev; Beer-Sheva 84105 Israel
| | - Riki Goldbart
- Department of Chemical Engineering; Ben-Gurion University of the Negev; Beer-Sheva 84105 Israel
| | - Joseph Kost
- Department of Chemical Engineering; Ben-Gurion University of the Negev; Beer-Sheva 84105 Israel
| | - Zulma Gazit
- Skeletal Biotech Laboratory; Hebrew University-Hadassah Faculty of Dental Medicine; Jerusalem Israel
- Department of Surgery; Cedars-Sinai Medical Center; Los Angeles CA 90048 United States
| | - Dan Gazit
- Skeletal Biotech Laboratory; Hebrew University-Hadassah Faculty of Dental Medicine; Jerusalem Israel
- Department of Surgery; Cedars-Sinai Medical Center; Los Angeles CA 90048 United States
| | - Gadi Pelled
- Skeletal Biotech Laboratory; Hebrew University-Hadassah Faculty of Dental Medicine; Jerusalem Israel
- Department of Surgery; Cedars-Sinai Medical Center; Los Angeles CA 90048 United States
| |
Collapse
|
4
|
Leblanc E, Drouin G, Grenier G, Faucheux N, Hamdy R. From skeletal to non skeletal: The intriguing roles of BMP-9: A literature review. ACTA ACUST UNITED AC 2013. [DOI: 10.4236/abb.2013.410a4004] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
|
5
|
Gene therapy approaches to regenerating bone. Adv Drug Deliv Rev 2012; 64:1320-30. [PMID: 22429662 DOI: 10.1016/j.addr.2012.03.007] [Citation(s) in RCA: 60] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/25/2011] [Revised: 02/13/2012] [Accepted: 03/05/2012] [Indexed: 02/07/2023]
Abstract
Bone formation and regeneration therapies continue to require optimization and improvement because many skeletal disorders remain undertreated. Clinical solutions to nonunion fractures and osteoporotic vertebral compression fractures, for example, remain suboptimal and better therapeutic approaches must be created. The widespread use of recombinant human bone morphogenetic proteins (rhBMPs) for spine fusion was recently questioned by a series of reports in a special issue of The Spine Journal, which elucidated the side effects and complications of direct rhBMP treatments. Gene therapy - both direct (in vivo) and cell-mediated (ex vivo) - has long been studied extensively to provide much needed improvements in bone regeneration. In this article, we review recent advances in gene therapy research whose aims are in vivo or ex vivo bone regeneration or formation. We examine appropriate vectors, safety issues, and rates of bone formation. The use of animal models and their relevance for translation of research results to the clinical setting are also discussed in order to provide the reader with a critical view. Finally, we elucidate the main challenges and hurdles faced by gene therapy aimed at bone regeneration as well as expected future trends in this field.
Collapse
|
6
|
Ren Y, Liu ZZ, Feng J, Wan H, Li JH, Wang H, Lin X. Association of a BMP9 haplotype with ossification of the posterior longitudinal ligament (OPLL) in a Chinese population. PLoS One 2012; 7:e40587. [PMID: 22829878 PMCID: PMC3400650 DOI: 10.1371/journal.pone.0040587] [Citation(s) in RCA: 34] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/10/2012] [Accepted: 06/10/2012] [Indexed: 12/11/2022] Open
Abstract
Direct or ex vivo BMP9 adenoviral gene therapy can induce massive bone formation at the injection sites and clearly promote spinal fusion. A comprehensive analysis of the osteogenic activity indicated that BMP9 was one of the most potent inducers of osteogenic differentiation both in vitro and in vivo among 14 types of human BMPs. However, genetic variations and whether they correlated with OPLL were not considered. We have sequenced the complete BMP9 gene in 450 patients with OPLL and in 550 matched controls. Analyses were performed on single markers and haplotypes. Single marker tests identified 6 SNPs, among which the minor alleles of rs7923671 (T>C; P = 0.0026; OR: 1.33, CI: 1.10–1.60), rs75024165 (C>T, Thr304Met; P<0.001; OR: 1.76, CI: 1.47–2.12) and rs34379100 (A>C; P<0.001; OR: 1.52, CI: 1.27–1.82) were associated with OPLL. Logistic regression analysis showed that the additive model of rs75024165 (TT vs. CT vs. CC; P<0.001; OR: 1.74) and rs34379100 (CC vs. AC vs. AA; P = 0.003; OR: 1.95) retained statistical significance when adjusted for clinical and demographic characteristics. Linkage disequilibrium (LD) analysis identified one 3 kb block of intense LD in BMP9 and one specific haplotype, CTCA (P<0.001; OR: 2.37), that contained the OPLL-associated risk alleles and was a risk factor for OPLL. This haplotype is associated with increased severity of OPLL, as shown by the distribution of ossified vertebrae in patients with OPLL (P = 0.001). In summary, in the Chinese population studied, SNPs in the BMP9 gene appear to contribute to the risk of OPLL in association with certain clinical and demographic characteristics. The severity of OPLL seems to be mediated predominantly by genetic variations in a 3kb BMP9 locus with the specific haplotype CTCA.
Collapse
Affiliation(s)
- Yuan Ren
- Department of Orthopaedics, Beijing Tiantan Hospital, Capital Medical University, Chongwen District, Beijing, China
| | - Zhi-zhong Liu
- Department of Clinic Laboratory, Beijing Tiantan Hospital, Capital Medical University, Chongwen District, Beijing, China
| | - Jie Feng
- Department of Institute of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Chongwen District, Beijing, China
| | - Hong Wan
- Department of Institute of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Chongwen District, Beijing, China
| | - Jun-hua Li
- Department of Institute of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Chongwen District, Beijing, China
| | - Hao Wang
- Department of Orthopaedics, Beijing Tiantan Hospital, Capital Medical University, Chongwen District, Beijing, China
| | - Xin Lin
- Department of Orthopaedics, Beijing Tiantan Hospital, Capital Medical University, Chongwen District, Beijing, China
- * E-mail:
| |
Collapse
|
7
|
Kimelman-Bleich N, Pelled G, Zilberman Y, Kallai I, Mizrahi O, Tawackoli W, Gazit Z, Gazit D. Targeted gene-and-host progenitor cell therapy for nonunion bone fracture repair. Mol Ther 2010; 19:53-9. [PMID: 20859259 DOI: 10.1038/mt.2010.190] [Citation(s) in RCA: 69] [Impact Index Per Article: 4.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/16/2022] Open
Abstract
Nonunion fractures present a challenge to orthopedics with no optimal solution. In-vivo DNA electroporation is a gene-delivery technique that can potentially accelerate regenerative processes. We hypothesized that in vivo electroporation of an osteogenic gene in a nonunion radius bone defect site would induce fracture repair. Nonunion fracture was created in the radii of C3H/HeN mice, into which a collagen sponge was placed. To allow for recruitment of host progenitor cells (HPCs) into the implanted sponge, the mice were housed for 10 days before electroporation. Mice were electroporated with either bone morphogenetic protein 9 (BMP-9) plasmid, Luciferase plasmid or injected with BMP-9 plasmid but not electroporated. In vivo bioluminescent imaging indicated that gene expression was localized to the defect site. Microcomputed tomography (µCT) and histological analysis of murine radii electroporated with BMP-9 demonstrated bone formation bridging the bone gap, whereas in the control groups the defect remained unbridged. Population of the implanted collagen sponge by HPCs transfected with the injected plasmid following electroporation was noted. Our data indicate that regeneration of nonunion bone defect can be attained by performing in vivo electroporation with an osteogenic gene combined with recruitment of HPCs. This gene therapy approach may pave the way for regeneration of other skeletal tissues.
Collapse
Affiliation(s)
- Nadav Kimelman-Bleich
- Skeletal Biotech Laboratory, Hebrew University-Hadassah Medical Center, Faculty of Dental Medicine, Jerusalem, Israel
| | | | | | | | | | | | | | | |
Collapse
|
8
|
Ye L, Kynaston H, Jiang WG. Bone Morphogenetic Protein-10 Suppresses the Growth and Aggressiveness of Prostate Cancer Cells Through a Smad Independent Pathway. J Urol 2009; 181:2749-59. [DOI: 10.1016/j.juro.2009.01.098] [Citation(s) in RCA: 32] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/09/2008] [Indexed: 01/08/2023]
Affiliation(s)
- Lin Ye
- Metastasis and Angiogenesis Research Group, Cardiff University School of Medicine, Heath Park, United Kingdom
| | - Howard Kynaston
- Metastasis and Angiogenesis Research Group, Cardiff University School of Medicine, Heath Park, United Kingdom
| | - Wen G. Jiang
- Metastasis and Angiogenesis Research Group, Cardiff University School of Medicine, Heath Park, United Kingdom
| |
Collapse
|
9
|
Teare JA, Ramoshebi LN, Ripamonti U. Periodontal tissue regeneration by recombinant human transforming growth factor-beta 3 in Papio ursinus. J Periodontal Res 2008; 43:1-8. [PMID: 18230100 DOI: 10.1111/j.1600-0765.2007.00987.x] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/23/2023]
Abstract
BACKGROUND AND OBJECTIVE Osteogenic proteins of the transforming growth factor-beta superfamily induce periodontal tissue regeneration in animal models, including primates. To our knowledge, no studies have been performed in periodontal regeneration using the transforming growth factor-beta 3 isoform. In the present study, recombinant human transforming growth factor-beta 3 was examined for its ability to induce periodontal tissue regeneration in the nonhuman primate, Papio ursinus. MATERIAL AND METHODS Class II furcation defects were surgically created bilaterally in the maxillary and mandibular molars of four adult baboons. Heterotopic ossicles, for transplantation to selected furcation defects, were induced within the rectus abdominis muscle by recombinant human transforming growth factor-beta 3. Forty days later, the periodontal defects were implanted with recombinant human transforming growth factor-beta 3 in Matrigel as the delivery system, with recombinant human transforming growth factor-beta 3 plus minced muscle tissue in Matrigel, or with the harvested recombinant human transforming growth factor-beta 3-induced ossicles. Sixty days after periodontal implantation, the animals were killed and the specimens harvested. Histological analysis on undecalcified sections measured the area and volume of new alveolar bone and the coronal extension of newly formed alveolar bone and cementum. RESULTS Morphometric analyses showed pronounced periodontal regeneration in experimental defects compared with controls. Substantial regeneration was observed in defects implanted with fragments of heterotopically induced ossicles and with recombinant human transforming growth factor-beta 3 plus minced muscle tissue. CONCLUSION Recombinant human transforming growth factor-beta 3 in Matrigel significantly enhanced periodontal tissue regeneration in the nonhuman primate, P. ursinus.
Collapse
Affiliation(s)
- J A Teare
- Bone Research Unit, Medical Research Council/University of the Witwatersrand, Johannesburg, South Africa
| | | | | |
Collapse
|
10
|
Siddappa R, Licht R, van Blitterswijk C, de Boer J. Donor variation and loss of multipotency during in vitro expansion of human mesenchymal stem cells for bone tissue engineering. J Orthop Res 2007; 25:1029-41. [PMID: 17469183 DOI: 10.1002/jor.20402] [Citation(s) in RCA: 246] [Impact Index Per Article: 14.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/04/2023]
Abstract
The use of multipotent human mesenchymal stem cells (hMSCs) for tissue engineering has been a subject of extensive research. The donor variation in growth, differentiation and in vivo bone forming ability of hMSCs is a bottleneck for standardization of therapeutic protocols. In this study, we isolated and characterized hMSCs from 19 independent donors, aged between 27 and 85 years, and investigated the extent of heterogeneity of the cells and the extent to which hMSCs can be expanded without loosing multipotency. Dexamethasone-induced ALP expression varied between 1.2- and 3.7-fold, but no correlation was found with age, gender, or source of isolation. The cells from donors with a higher percentage of ALP-positive cells in control and dexamethasone-induced groups showed more calcium deposition than cells with lower percentage of ALP positive cells. Despite the variability in osteogenic gene expression among the donors tested, ALP, Collagen type 1, osteocalcin, and S100A4 showed similar trends during the course of osteogenic differentiation. In vitro expansion studies showed that hMSCs can be effectively expanded up to four passages (approximately 10-12 population doublings from a P0 culture) while retaining their multipotency. Our in vivo studies suggest a correlation between in vitro ALP expression and in vivo bone formation. In conclusion, irrespective of age, gender, and source of isolation, cells from all donors showed osteogenic potential. The variability in ALP expression appears to be a result of sampling method and cellular heterogeneity among the donor population.
Collapse
Affiliation(s)
- Ramakrishnaiah Siddappa
- Institute for BioMedical Technology, Department of Tissue Regeneration, University of Twente, Zuidhorst, P.O. Box 217, Enschede 7500 AE, The Netherlands
| | | | | | | |
Collapse
|
11
|
Kimelman N, Pelled G, Gazit Z, Gazit D. Applications of gene therapy and adult stem cells in bone bioengineering. Regen Med 2007; 1:549-61. [PMID: 17465849 DOI: 10.2217/17460751.1.4.549] [Citation(s) in RCA: 25] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/06/2023] Open
Abstract
Bone tissue engineering is an emerging field, that could become a main therapeutic strategy in orthopedics in coming years. While bone has regenerative abilities that enable the self repair and regeneration of fractures, there are extreme situations in which the extent of bone loss is too large for complete regeneration to occur. In order to achieve bone regeneration, osteogenic genes (mainly from the bone morphogenetic protein family) can be delivered either directly into the target tissue, or by using adult stem cells, which are later implanted into the target site. Engineered adult stem cells combined with biodegradable polymeric scaffolds can be implanted into target sites, with or without ex vivo culture period. Several important factors influence the success of bone engineering approaches including: choice of cell and scaffold, the vector used in order to deliver the osteogenic gene, and the osteogenic gene itself. Cutting-edge imaging technologies, bioinformatics-based analysis of gene expression and exogenous regulation of transgene expression are among the tools that are being used to optimize and control bone formation in vivo. In this review we have attempted to provide an overview of the main factors that should be considered when utilizing adult stem cells and gene therapy strategies to regenerate bone defects or to promote new bone formation in vivo.
Collapse
Affiliation(s)
- N Kimelman
- The Hebrew University of Jerusalem, Skeletal Biotechnology Laboratory, Hadassah Medical Campus, Ein Kerem, PO Box 12272, Jerusalem, 91120, Israel
| | | | | | | |
Collapse
|